| Title: |
A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncology Group study |
| Authors: |
Schilder, R.J.; Sill, M.W.; Lankes, H.A.; Gold, M.A.; Mannel, R.S.; Modesitt, S.C.; Hanjani, P.; Bonebrake, A.J.; Sood, A.K.; Godwin, A.K.; Hu, W.; Alpaugh, R.K. |
| Contributors: |
National Cancer Institute |
| Source: |
Gynecologic Oncology ; volume 129, issue 1, page 86-91 ; ISSN 0090-8258 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2013 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.ygyno.2013.01.006 |
| Availability: |
http://dx.doi.org/10.1016/j.ygyno.2013.01.006; https://api.elsevier.com/content/article/PII:S0090825813000164?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0090825813000164?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ |
| Accession Number: |
edsbas.1B796DA4 |
| Database: |
BASE |